drugset / Trial / NCT02175602
Study of Drug Combination on Pharmacokinetics in Healthy Volunteers
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the effect of Daclatasvir, Asunaprevir, and BMS-791325 on the pharmacokinetics of selective serotonin reuptake inhibitors.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asunaprevir | Small molecule | 200 mg | Oral |
| Subject | Beclabuvir | Small molecule | 75 mg | Oral |
| Subject | Daclatasvir | Small molecule | 30 mg | Oral |
| Subject | Escitalopram | Small molecule | 10 mg | — |
| Subject | Sertraline | Small molecule | 50 mg | — |